Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma LesionsWon Young Tak, Riccardo Lencioni, Shi-Ming Lin et al.|Clinical Cancer Research|2017Cited by 166
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)Yihebali Chi, Jianqiang Cai, Yongqian Shu et al.|The Oncologist|2021Cited by 64
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC)Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro et al.|Journal of Clinical Oncology|2014Cited by 60
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Chi Yang, Jun Zhou, Jia Fan et al.|Liver Cancer|2022Cited by 22